Salute H24

A possible downturn in rate of new cases of diabetes #EASD2019

While overall, the numbers (prevalence) of people with type 2 diabetes continue to grow at an alarming rate, new research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that recent studies suggest the rate at which new cases develop (incidence) may be falling. The study is by Professor Dianna Magliano and Professor Jonathan Shaw, Baker Heart and Diabetes Institute, Melbourne, Australia, and colleagues.

Reducing secondary mitral regurgitation in heart failure does not improve two-year outcome #ESCCongress #ESC2019

Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not lower death and hospitalisation at two years compared to standard medical care, according to late breaking results from the MITRA-FR study presented in a Hot Line Session at ESC Congress 2019 in Paris together with the World Congress of Cardiology and published in the European Journal of Heart Failure.

Diabetes and heart attack is a particularly risky combination #ESCCongress #ESC2019 #WCC2019

After a heart attack, patients with diabetes are at greater risk of heart failure and subsequent death than those without diabetes, according to late breaking results from the FAST-MI registry presented at ESC Congress 2019 together with the World Congress of Cardiology in Paris. (1)

Eating nuts linked with lower risk of fatal heart attack and stroke #ESCCongress #ESC2019

Eating nuts at least twice a week is associated with a 17% lower risk of death from cardiovascular disease, according to research presented at ESC Congress 2019 together with the World Congress of Cardiology. (1)

Chronic coronary syndromes: Pollution and noise reduction advised in ESC guidelines #ESCCongress #ESC2019

The detrimental impact of pollution and noise on patients with chronic coronary syndromes is highlighted for the first time in European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal, (1) and on the ESC website. (2)

Pollution and winter linked with rise in heart attack treatment #ESCCongress #ESC2019

Heavily polluted areas have a higher rate of angioplasty procedures to treat blocked arteries than areas with clean air, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology. (1) Procedures are even more common in winter, the most polluted time of year.

Junk food intake in children reduced by health education that addresses emotional issues #ESCCongress #ESC2019

Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research will be presented at ESC Congress 2019 together with the World Congress of Cardiology. (1) The study suggests that knowledge alone is insufficient to change behaviour.

Targeted therapy combination improves survival in patients with advanced bowel cancer

New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer. Results of the BEACON CRC phase III trial have shown that triple therapy targeting BRAF mutations in progressive metastatic colorectal tumours significantly improved overall survival and objective response compared to standard care. (1)

The costs of cancer in 2015: 8.7 million years of life and $94 billion in lost earnings

Cancer took more than 8.7 million years of life and $94.4 billion in lost earnings among people ages 16 to 84 in the United States in 2015. The calculation comes from a new report by American Cancer Society researchers that appears early online in JAMA Oncology.

FDA approves daratumumab for multiple myeloma ineligible for autologous stem cell transplant

On June 27, 2019, the Food and Drug Administration approved daratumumab (DARZALEX, Janssen Biotech, Inc.) in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.